Folks, no suitor is gonna finalize a price and pull the trigger while an important end-of-Phase-2 FDA meeting is pending. That is a potentially vital DD step, so it has to be concluded. And this is not to say that there aren't other DD matters pending, just that this is one we can be sure of.
It seems to me that the logical course of action for any acquirer/partner is to let IPIX go bankrupt and then pick up the pieces at much lower cost. I think potential partners have recognized for several years that IPIX was on the ropes regarding funding, and realized that waiting for IPIX bankruptcy was the most cost effective course of action. I wish I had tumbled to this strategy earlier. :(